We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,722

China's crackdown on counterfeit medicines won "IPR Defenders Award" in the United States
  • Unitalen
  • China, USA
  • April 28 2014

The "Cloud Action" by Chinese police to combat cyber crime of producing and selling fake drugs, won the "IPR Defenders Award" awarded by the Global


Competition policy v IP
  • Bristows LLP
  • European Union, United Kingdom
  • May 8 2016

Conceptually, intellectual property rights (IPRs) and competition law appear to be at odds: the former grants temporary monopolies and the latter


Competition Bureau turns its focus to IP rights in the pharmaceutical industry
  • Baker & McKenzie
  • Canada
  • May 13 2014

Following trends towards increased enforcement activity and a heightened focus on intellectual property in the pharmaceutical industry, the


China newsletter, Summer 2014 No. 27
  • Greenberg Traurig LLP
  • China
  • July 31 2014

On February 20, 2014, the State Administration for Industry and Commerce published the Administrative Provisions on the Registration of the


PMPRB issues discussion paper on options to address the Federal Court decision in LEO Pharma
  • Gowling WLG
  • Canada
  • February 6 2008

The Patented Medicine Prices Review Board (PMPRB) has issued a discussion paper outlining a series of options to address the implications of the Federal Court of Canada decision in the LEO Pharma case


Intellectual property & life sciences 2013: legal developments you need to know about
  • Mayer Brown LLP
  • European Union, United Kingdom
  • January 10 2013

Since 1 January 2013 data processors have been able to implement BCRs to facilitate the movement of personal data outside the EU. The Article 29


Counterfeit drugs
  • Fasken Martineau DuMoulin LLP
  • Africa
  • December 4 2012

Over 80 million dollars' worth of counterfeit pharmaceuticals were seized over a three-day period last July in several African ports at the close of an international customs operation


Governmental incentives for biotech R&D projects
  • Nctm Studio Legale
  • Italy
  • January 9 2014

The Italian Ministry of Economic Development offers 5 million incentives for innovative R&D projects in all fields of modern biotechnology


Amendments to the Patented Medicines (Notice of Compliance) Regulations - registered on June 12, 2008
  • Gowling WLG
  • Canada
  • June 19 2008

In our Pharmacapsules edition that was published on May 8, 2008, we reported on the proposed amendments to the Patented Medicines (Notice of Compliance) Regulations ("Regulations") that the Canadian Government recently published in the Canada Gazette


Litigating patent obviousness
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • October 31 2008

Sound patent protection is a necessity to justify the time and expense of developing new pharmaceutical products